Published in J Chromatogr on November 01, 1978
Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol (1980) 0.80
Intoxication with pyrazolones. Br J Clin Pharmacol (1980) 0.78
Randomized comparative trial of triflusal and aspirin following acute myocardial infarction. Eur Heart J (2000) 1.43
Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos (1997) 1.17
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function. J Clin Pharmacol (1997) 0.95
High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. J Chromatogr B Biomed Appl (1996) 0.94
Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1985) 0.94
Quantitative assay of diclofenac in biological material by gas-liquid chromatography. J Chromatogr (1975) 0.93
Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther (1997) 0.93
Determination of artemether and its metabolite, dihydroartemisinin, in plasma by high-performance liquid chromatography and electrochemical detection in the reductive mode. J Chromatogr B Biomed Sci Appl (1997) 0.90
[The percutaneous absorption of diclofenac]. Arzneimittelforschung (1986) 0.90
Gas chromatographic determination of amantadine hydrochloride (Symmetrel) in human plasma and urine. J Chromatogr (1980) 0.88
Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations. Am Heart J (1989) 0.88
Gas chromatographic determination of oxprenolol in human plasma. J Chromatogr (1983) 0.88
Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids. J Pharm Sci (1994) 0.88
Gas chromatographic determination of metoprolol in human plasma. J Chromatogr (1983) 0.86
Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection. J Chromatogr B Biomed Sci Appl (2001) 0.82
Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. Eur J Clin Pharmacol (1997) 0.82
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Clin Cancer Res (1999) 0.82
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol (1993) 0.81
The effect of age on the pharmacokinetics of valsartan. Biopharm Drug Dispos (1998) 0.80
GLC determination of free and conjugated triclosan in human plasma and urine. J Pharm Sci (1977) 0.80
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Eur J Clin Pharmacol (1994) 0.79
Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Sci Appl (1997) 0.79
Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration. Biopharm Drug Dispos (1998) 0.78
GLC determination of alpha- and beta-tribenosides in human plasma. J Pharm Sci (1980) 0.78
Pharmacokinetics of chlorthalidone in the elderly after single and multiple doses. Br J Clin Pharmacol (1983) 0.75
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. Br J Clin Pharmacol (1984) 0.75
Influence of exercise on nitroglycerin plasma concentrations after transdermal application. Br J Clin Pharmacol (1990) 0.75
High-performance liquid chromatographic determination of sulphathiazole in human plasma and urine. J Chromatogr (1980) 0.75
Gas chromatographic determination of low concentrations of benzoic acid in human plasma and urine. J Chromatogr (1980) 0.75
Biotransformation of tribenoside into benzoic acid in man. Eur J Drug Metab Pharmacokinet (1982) 0.75
Gas chromatographic determination of N-desmethyl-propyphenazone, a metabolite of propyphenazone, in human urine. J Chromatogr (1980) 0.75
Determination of the two dinitrate metabolites of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1987) 0.75
Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. Eur J Drug Metab Pharmacokinet (1991) 0.75
Simultaneous determination of isosorbide dinitrate and its mononitrate metabolites in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr B Biomed Appl (1996) 0.75
Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol (1989) 0.75
Plasma deproteinization by precipitation and filtration in the 96-well format. J Pharm Biomed Anal (2001) 0.75
GLC determination of phenylbutazone in human plasma. J Pharm Sci (1978) 0.75
[Cyclic-AMP]. Pathol Biol (Paris) (1970) 0.75
Determination of acenocoumarol in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1994) 0.75
[Transport of sodium diclofenac into synovial fluid]. Therapie (1984) 0.75
Determination of oxyphenbutazone in human plasma by high-performance liquid chromatography. J Chromatogr (1983) 0.75
Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. J Pharm Sci (1980) 0.75
Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers. Eur J Clin Pharmacol (1995) 0.75
Gas chromatographic determination of phentolamine (Regitine) in human plasma and urine. J Chromatogr (1981) 0.75
Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1995) 0.75
Determination of pirprofen in biological material by gas-liquid chromatography with nitrogen-specific and electron-capture detection. J Chromatogr (1984) 0.75
Gas chromatographic determination of valproic acid in human plasma. J Chromatogr (1980) 0.75
Stereospecific high-performance liquid chromatographic determination of an S(-)-benzopyran methyl ester derivative (CGP 50 068), its (-)-carboxylic acid metabolite (CGP 55 461) and the related (+)-enantiomer (CGP 54 228) in human and dog plasma. J Chromatogr B Biomed Appl (1995) 0.75
Bioequivalence assessment: a pharmaceutical industry perspective. Eur J Drug Metab Pharmacokinet (1996) 0.75
Gas chromatographic determination of maprotiline and its N-desmethyl metabolite in human blood using nitrogen detection. J Chromatogr (1980) 0.75
[Comparative elimination of pirprofen from the plasma and synovial fluid of the knee. 26 cases]. Presse Med (1983) 0.75
[Blood concentrations of maprotiline in depressive patients]. Encephale (1989) 0.75
Simultaneous determination of pirprofen and its metabolite, the pyrrole derivative, in plasma by high-performance liquid chromatography. J Chromatogr (1985) 0.75
Determination of the (+)- and (-)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography. J Chromatogr (1987) 0.75
Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr (1984) 0.75
Practice of solid-phase extraction and protein precipitation in the 96-well format combined with high-performance liquid chromatography-ultraviolet detection for the analysis of drugs in plasma and brain. J Chromatogr B Biomed Sci Appl (2001) 0.75
Determination of isosorbide as a metabolite of isosorbide dinitrate in human urine by capillary gas chromatography with electron-capture detection. J Chromatogr (1983) 0.75
High-performance liquid chromatographic determination of pirprofen and five of its metabolites in human plasma without hydrolysis and in human urine before and after chemical hydrolysis. J Chromatogr (1989) 0.75
Gas chromatographic determination of clioquinol (Vioform) in human plasma. J Chromatogr (1981) 0.75
Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr A (1996) 0.75
Gas chromatographic determination of phenazone derivatives in human plasma. I. Aminophenazone. J Chromatogr (1978) 0.75
Gas chromatographic determination of isosorbide dinitrate in human plasma and urine. J Chromatogr (1982) 0.75
[Effect of 3 antacids on the bioavailability of pirprofen]. Therapie (1984) 0.75